Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2014
02/06/2014WO2014020155A1 Oral transmucosal adminstration forms of s-ketamine
02/06/2014WO2014020130A2 Albumin composition
02/06/2014WO2014020067A1 Compositions for alleviating gastrointestinal tract disorders or associated systemic disorders in ruminants and camelids
02/06/2014WO2014020039A1 Lozenges with multiple release kinetics for active ingredients
02/06/2014WO2014019972A1 Injectable compositions comprising letrozole or anastrozole
02/06/2014WO2014019842A1 Kit, use thereof and method for filling connective tissue of the skin
02/06/2014WO2014019556A1 Alaptide : methods of effecting its solubility, membrane permeation and pharmaceutical compositions for human and/or veterinary applications
02/06/2014WO2014019555A1 Vesicles which include epidermal growth factor and compositions that contain same
02/06/2014WO2014019452A1 Physical antimicrobial method
02/06/2014WO2014019095A1 Resiniferatoxin solution
02/06/2014WO2014019017A1 A herbal formulation for treating a menstrual-related condition
02/06/2014WO2013188819A3 Mucoadhesive devices for delivery of active agents
02/06/2014WO2013188627A3 Cationic lipid vaccine compositions and methods of use
02/06/2014WO2013188279A8 Topical ophthalmological pharmaceutical composition containing cediranib
02/06/2014WO2013175511A4 Taste masked pharmaceutical compositions
02/06/2014WO2013012199A8 Capsule formulation comprising montelukast and levocetirizine
02/06/2014US20140039121 Preparation of Polyphosphazene Microspheres
02/06/2014US20140039070 Compositions and methods of delivery of pharmacological agents
02/06/2014US20140039069 Compositions and methods of delivery of pharmacological agents
02/06/2014US20140039058 Ophthalmic solution
02/06/2014US20140039057 Compositions
02/06/2014US20140039028 Transdermal formulation containing cox inhibitors
02/06/2014US20140039017 Therapeutic combination
02/06/2014US20140039015 Methods of using sustained release aminopyridine compositions
02/06/2014US20140039000 Liquid pharmaceutical formulations of palonosetron
02/06/2014US20140038997 Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
02/06/2014US20140038996 Freeze Dried Drug Nanosuspensions
02/06/2014US20140038972 Alpha-2 agonist polymeric drug delivery systems
02/06/2014US20140037769 Method for manufacturing pure guar flour
02/06/2014US20140037748 Redox responsive polymeric nanocapsules for protein delivery
02/06/2014US20140037747 Amphiphilic dendron-coils, micelles thereof and uses
02/06/2014US20140037746 Polymer-based, sustained release drug delivery system
02/06/2014US20140037745 Controlled release compositions of gamma-hydroxybutyrate
02/06/2014US20140037744 Microcapsules containing an oxidizable active, and a process for preparing the same
02/06/2014US20140037743 Microencapsulated bioactive agents for oral delivery and methods of use thereof
02/06/2014US20140037742 Alginate microparticles and methods of using the same
02/06/2014US20140037741 Novel nanoparticles
02/06/2014US20140037738 Transdermal formulation containing cox inhibitors
02/06/2014US20140037737 Particles for use in a pharmaceutical composition
02/06/2014US20140037735 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
02/06/2014US20140037734 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
02/06/2014US20140037731 Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery
02/06/2014US20140037730 Compositions for the symptomatic relief of stomach pain or gastrooesophageal reflux
02/06/2014US20140037728 Dosage forms for oral administration and methods of treatment using the same
02/06/2014US20140037727 Tablet Of Paracetamol Containing An Encapsulated Flavorant
02/06/2014US20140037726 Novel pharmaceutical composition
02/06/2014US20140037725 Bilayer pharmaceutical compositions of naproxen
02/06/2014US20140037723 Low Dose Topiramate/Phentermine Composition And Methods Of Use Thereof
02/06/2014US20140037722 Methods and compositions of camel derived products
02/06/2014US20140037721 Pharmaceutical Composition
02/06/2014US20140037720 Controlled release pharmaceutical compositions comprising a fumaric acid ester
02/06/2014US20140037718 Transdermal pain gel
02/06/2014US20140037715 Disulfiram formulation and uses thereof
02/06/2014US20140037714 Amino acid lipids and uses thereof
02/06/2014US20140037713 Transdermal compositions for anti-cholinergic agents
02/06/2014US20140037712 Methods for preventing or treating eye diseases using adiponectin
02/06/2014US20140037710 Method for producing patch, and patch
02/06/2014US20140037709 Method of Protecting Active Ingredients From Degradation During Pelleting
02/06/2014US20140037708 Composition for spatio and/or temporal release of bioactive material
02/06/2014US20140037698 Additives for animal food
02/06/2014US20140037697 Particulate materials
02/06/2014US20140037611 Treatment of Pompe's Disease
02/06/2014US20140037588 Injectable thermoresponsive polyelectrolytes
02/06/2014US20140035184 Extended release biodegradable ocular implants
02/06/2014DE102013011399A1 Rod-shaped biodegradable implant useful for maintenance therapy in schizophrenia in patients comprises risperidone
02/05/2014EP2693259A1 Lens incorporating myopia control optics and muscarinic agents
02/05/2014EP2692777A1 Pharmaceutical composition containing block copolymer comprising boric acid compound
02/05/2014EP2692742A1 Novel preparation technique for higher-order structure that exhibits anti-cellular effect
02/05/2014EP2692516A2 Method of producing solid material and compression molding machine
02/05/2014EP2692360A1 Fat emulsion containing prostaglandin
02/05/2014EP2692348A1 Antitumor agent containing carbon dioxide as active ingredient
02/05/2014EP2692347A1 Ointment with excellent formulation stability
02/05/2014EP2692344A1 Combination therapy for treatment of Multiple sclerosis
02/05/2014EP2692343A1 Combination therapy for treatment of multiple sclerosis
02/05/2014EP2692342A1 Process for the preparation of pharmaceutical compositions comprising febuxostat in the form of tablets
02/05/2014EP2692341A1 Abuse resistant drug formulation
02/05/2014EP2692340A1 Stable pharmaceutical system (kit) for the preparation of oral solution of levothyroxine or pharmaceutically acceptable salt thereof
02/05/2014EP2692337A1 Film-shaped externally used drug composition
02/05/2014EP2692336A1 Externally used drug kit
02/05/2014EP2692334A1 Vesicle composition
02/05/2014EP2692331A1 Carotenoid-containing composition and method for producing same
02/05/2014EP2691569A1 Binder and process for producing fabrics containing cyclodextrins fixed by said binder
02/05/2014EP2691369A1 Prodrugs of d-isoglutamyl-[d/l]-tryptophan
02/05/2014EP2691120A2 Theranostic imaging agents and methods of use
02/05/2014EP2691116A1 Nanoparticles loaded with chemotherapeutic antitumoral drug
02/05/2014EP2691114A1 Delivery of large molecular weight biologically active substances
02/05/2014EP2691101A2 Delivery and formulation of engineered nucleic acids
02/05/2014EP2691100A2 Intranasal benzodiazepine pharmaceutical compositions
02/05/2014EP2691087A2 Pharmaceutical composition containing no, process for the preparation and use thereof
02/05/2014EP2691086A1 Compositions for the treatment of neurologic disorders
02/05/2014EP2691085A1 Film-forming composition for a ph-dependant sustained release of the active agent
02/05/2014EP2691084A1 Method for encapsulated therapeutic products and uses thereof
02/05/2014EP2691083A1 Pharmaceutical composition of sitagliptin
02/05/2014EP2691082A2 Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
02/05/2014EP2691081A1 Sustained-release injectable formulation
02/05/2014EP2691080A1 Menthol liquids composition
02/05/2014EP2691079A2 Biodegradable compositions suitable for controlled release
02/05/2014EP2691078A1 Biodegradable compositions suitable for controlled release
02/05/2014EP2691077A1 Salicylic acid topical formulation
02/05/2014EP2691076A1 Usnic acid topical formulation
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 2991